Skip to main content
رجوع
Watch Compare

Silo Pharma, Inc.

جودة البيانات: 100%
SILO
NASDAQ Manufacturing Chemicals
KWD 0.40
▲ KWD 0.00 (1.00%)
6 months return
—
Momentum
Neutral
ROE
-85.18%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)0.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-85.18%
أقل من متوسط القطاع (-54.68%)
ROIC-59.97%
Net Margin-5863.50%
Op. Margin-5936.95%

الأمان

Debt / Equity
N/A
Current Ratio8.70
Interest Coverage-114.76

التقييم

PE (TTM)
-1.70
أقل من متوسط القطاع (-1.50)
P/B Ratio1.43
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -4.66 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

مفاجآت الأرباح

EPS
Reported Estimate
Q32023 Q42023
Reported -KWD 0.21 -KWD 0.36
Estimate -KWD 0.31 -KWD 0.20
المفاجأة +32.26% -80.00%

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 0.00% Revenue Growth (3Y) 0.00%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -85.18% · Net Margin: -5863.50%
Revenue (TTM) 72,102.0 Net Income (TTM) -4.23 M
ROE -85.18% ROA -64.86%
Gross Margin 38.57% Operating Margin -5936.95%
Net Margin -5863.50% Free Cash Flow (TTM) -4.66 M
ROIC -59.97% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 8.70
Debt / Equity N/A Current Ratio 8.70
Interest Coverage -114.76 Asset Turnover 0.01
Working Capital 5.46 M Tangible Book Value 4.79 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -1.70 · EV/EBITDA: N/A
P/E Ratio -1.70 Forward P/E N/A
P/B Ratio 1.43 P/S Ratio 99.49
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -64.98%
Market Cap 7.17 M Enterprise Value 3.26 M

Per Share

EPS: -0.50 · FCF/Share: -0.29
EPS (Diluted TTM) -0.50 Revenue / Share 0.00
FCF / Share -0.29 OCF / Share -0.29
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 110.26% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 110.26%
SBC-Adj. FCF -4.89 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 72,102.0 72,102.0 72,102.0 — —
Net Income -4.23 M -4.39 M -3.70 M -3.91 M 3.90 M
EPS (Diluted) -0.50 -1.19 — — 0.04
Gross Profit 27,807.0 66,264.0 66,264.0 66,264.0 66,260.0
Operating Income -4.28 M -4.71 M -3.86 M -3.63 M -2.74 M
EBITDA — — — — —
R&D Expenses 2.16 M 2.37 M 845,092.0 1.29 M 693,910.0
SG&A Expenses — — 390,071.0 227,259.0 162,953.0
D&A — — — — —
Interest Expense 37,302.0 5,084.0 4,869.0 2,199.0 54.0
Income Tax — — — 24,876.0 24,876.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 7.61 M 7.41 M 7.75 M 11.64 M 10.49 M
Total Liabilities 1.30 M 2.38 M 1.57 M 1.30 M 1.43 M
Shareholders' Equity 6.31 M 5.03 M 6.18 M 10.34 M 9.06 M
Total Debt — — — — —
Cash & Equivalents 4.75 M 3.91 M 3.52 M 11.37 M 9.84 M
Current Assets 7.39 M 7.11 M 7.68 M 11.57 M 10.40 M
Current Liabilities 650,183.0 1.66 M 775,590.0 436,318.0 490,039.0

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E -1.7 -1.5
P/B 1.4 1.6
ROE % -85.2 -54.7
Net Margin % -5863.5 -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3

ETFs Holding This Stock
PSIL logo PSIL AdvisorShares Psychedelics ETF
1.47% weight
AVXC logo AVXC Avantis Emerging Markets ex-China Equity ETF
0.02% weight
AVES logo AVES Avantis Emerging Markets Value ETF
0.00% weight